JP2018009002A5 - - Google Patents

Download PDF

Info

Publication number
JP2018009002A5
JP2018009002A5 JP2017155229A JP2017155229A JP2018009002A5 JP 2018009002 A5 JP2018009002 A5 JP 2018009002A5 JP 2017155229 A JP2017155229 A JP 2017155229A JP 2017155229 A JP2017155229 A JP 2017155229A JP 2018009002 A5 JP2018009002 A5 JP 2018009002A5
Authority
JP
Japan
Prior art keywords
pharmaceutical preparation
cells
mesenchymal stem
cultured
genetically engineered
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017155229A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018009002A (ja
JP6757300B2 (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2018009002A publication Critical patent/JP2018009002A/ja
Publication of JP2018009002A5 publication Critical patent/JP2018009002A5/ja
Application granted granted Critical
Publication of JP6757300B2 publication Critical patent/JP6757300B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2017155229A 2004-03-22 2017-08-10 間葉幹細胞及びその使用法 Expired - Lifetime JP6757300B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US55511804P 2004-03-22 2004-03-22
US60/555,118 2004-03-22

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2017003854A Division JP6382360B2 (ja) 2004-03-22 2017-01-13 間葉幹細胞及びその使用法

Related Child Applications (2)

Application Number Title Priority Date Filing Date
JP2018190636A Division JP6757383B2 (ja) 2004-03-22 2018-10-09 間葉幹細胞及びその使用法
JP2020047240A Division JP7033159B2 (ja) 2004-03-22 2020-03-18 間葉幹細胞及びその使用法

Publications (3)

Publication Number Publication Date
JP2018009002A JP2018009002A (ja) 2018-01-18
JP2018009002A5 true JP2018009002A5 (enExample) 2018-04-19
JP6757300B2 JP6757300B2 (ja) 2020-09-16

Family

ID=46060822

Family Applications (8)

Application Number Title Priority Date Filing Date
JP2012058539A Expired - Lifetime JP6114500B2 (ja) 2004-03-22 2012-03-15 間葉幹細胞及びその使用法
JP2014241859A Expired - Lifetime JP5997237B2 (ja) 2004-03-22 2014-11-28 間葉幹細胞及びその使用法
JP2017003854A Expired - Lifetime JP6382360B2 (ja) 2004-03-22 2017-01-13 間葉幹細胞及びその使用法
JP2017155229A Expired - Lifetime JP6757300B2 (ja) 2004-03-22 2017-08-10 間葉幹細胞及びその使用法
JP2018190636A Expired - Lifetime JP6757383B2 (ja) 2004-03-22 2018-10-09 間葉幹細胞及びその使用法
JP2020047240A Expired - Lifetime JP7033159B2 (ja) 2004-03-22 2020-03-18 間葉幹細胞及びその使用法
JP2021140167A Expired - Lifetime JP7546239B2 (ja) 2004-03-22 2021-08-30 間葉幹細胞及びその使用法
JP2023023996A Pending JP2023065486A (ja) 2004-03-22 2023-02-20 間葉幹細胞及びその使用法

Family Applications Before (3)

Application Number Title Priority Date Filing Date
JP2012058539A Expired - Lifetime JP6114500B2 (ja) 2004-03-22 2012-03-15 間葉幹細胞及びその使用法
JP2014241859A Expired - Lifetime JP5997237B2 (ja) 2004-03-22 2014-11-28 間葉幹細胞及びその使用法
JP2017003854A Expired - Lifetime JP6382360B2 (ja) 2004-03-22 2017-01-13 間葉幹細胞及びその使用法

Family Applications After (4)

Application Number Title Priority Date Filing Date
JP2018190636A Expired - Lifetime JP6757383B2 (ja) 2004-03-22 2018-10-09 間葉幹細胞及びその使用法
JP2020047240A Expired - Lifetime JP7033159B2 (ja) 2004-03-22 2020-03-18 間葉幹細胞及びその使用法
JP2021140167A Expired - Lifetime JP7546239B2 (ja) 2004-03-22 2021-08-30 間葉幹細胞及びその使用法
JP2023023996A Pending JP2023065486A (ja) 2004-03-22 2023-02-20 間葉幹細胞及びその使用法

Country Status (5)

Country Link
JP (8) JP6114500B2 (enExample)
AT (1) ATE556134T1 (enExample)
CA (3) CA2934682C (enExample)
ES (7) ES2544689T3 (enExample)
TR (1) TR201901268T4 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2934682C (en) * 2004-03-22 2021-12-07 Mesoblast International Sarl Mesenchymal stem cells and uses therefor
EP2298861B1 (en) * 2004-03-22 2017-09-13 Mesoblast International Sàrl Mesenchymal stem cells and uses therefor
EP2849765A4 (en) * 2012-05-16 2015-12-02 Univ Johns Hopkins STEM CELLS AS INDIVIDUALIZED MATERNAL THERAPY FOR THE PREVENTION OF EARLY BIRTHS
JP2016210730A (ja) * 2015-05-08 2016-12-15 上田　実 医薬組成物及びその製造方法並びに医薬品
WO2018092769A1 (ja) 2016-11-15 2018-05-24 株式会社カネカ 胎児付属物に由来する間葉系幹細胞を含む細胞集団とその製造方法、及び医薬組成物
CN112004923A (zh) 2017-11-22 2020-11-27 迈索布拉斯特国际有限公司 细胞组合物及治疗方法
WO2019132026A1 (ja) 2017-12-28 2019-07-04 株式会社カネカ 接着性幹細胞を含む細胞集団とその製造方法、及び医薬組成物
EP3984596A4 (en) 2019-06-14 2023-06-21 Kaneka Corporation POPULATION OF CELLS COMPRISING MESENCHYMATOUS CELLS, PHARMACEUTICAL COMPOSITION COMPRISING THEM AND METHOD FOR PRODUCTION THEREOF
EP4013856A1 (en) * 2019-08-15 2022-06-22 NextCell Pharma AB Allogeneic composition for treatment of cns disorders
CN113813288B (zh) * 2021-08-11 2024-02-13 谢岩 间充质干细胞及包含其的组合物用于制备治疗烧伤难愈创面的药物的用途

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0651641B2 (ja) * 1983-08-29 1994-07-06 株式会社ミドリ十字 ガンマ・インターフェロン組成物
JPH01501792A (ja) * 1986-03-17 1989-06-22 シェリング・コーポレーション γ型インターフェロンによる癌の治療
CA2191733A1 (en) * 1994-06-07 1995-12-21 Daniel A. Vallera Methods for inhibiting antigen specific t cell responses
US6497875B1 (en) * 1996-04-26 2002-12-24 Case Western Reserve University Multilayer skin or dermal equivalent having a layer containing mesenchymal stem cells
CA2320040C (en) * 1998-03-18 2007-05-22 Osiris Therapeutics, Inc. Mesenchymal stem cells for prevention and treatment of immune responses in transplantation
US6368636B1 (en) * 1998-03-18 2002-04-09 Osiris Therapeutics, Inc. Mesenchymal stem cells for prevention and treatment of immune responses in transplantation
US6797269B2 (en) * 1998-04-03 2004-09-28 Osiris Therapeutics, Inc. Mesenchymal stem cells as immunosuppressants
AU2001229254B2 (en) * 2000-01-19 2006-07-27 Gill, Parkash S. Pharmaceutical compositions and methods of treatment based on VEGF antisense oligonucleotides
ES2353061T5 (es) * 2000-04-25 2014-04-07 Osiris Therapeutics, Inc. Reparación de articulaciones utilizando células madre mesenquimatosas
MXPA04007426A (es) * 2002-02-01 2004-10-11 Schering Corp Usos de citosina de mamifero; reactivos relacionados.
JP3897343B2 (ja) * 2002-08-01 2007-03-22 株式会社林原生物化学研究所 免疫担当細胞においてインターフェロン−γの産生を誘導する蛋白質
WO2004052177A2 (en) * 2002-12-05 2004-06-24 Case Western Reserve University Cell-based therapies for ischemia
CA2934682C (en) * 2004-03-22 2021-12-07 Mesoblast International Sarl Mesenchymal stem cells and uses therefor
EP2298861B1 (en) * 2004-03-22 2017-09-13 Mesoblast International Sàrl Mesenchymal stem cells and uses therefor

Similar Documents

Publication Publication Date Title
JP2018009002A5 (enExample)
JP2017080507A5 (enExample)
Xie et al. What is the impact of human umbilical cord mesenchymal stem cell transplantation on clinical treatment?
JP2018109052A5 (enExample)
JP2017081972A5 (enExample)
JP2022023092A5 (enExample)
Conti et al. IL-10, an inflammatory/inhibitory cytokine, but not always
Amoah et al. Immunopathogenesis of myocarditis: the interplay between cardiac fibroblast cells, dendritic cells, macrophages and CD 4+ T cells
JP2018526447A5 (enExample)
JP2011116788A5 (enExample)
Che et al. Mesenchymal stem/stromal cells in the pathogenesis and regenerative therapy of inflammatory bowel diseases
CN104884076A (zh) 利用了hmgb1片段的新型心肌梗塞的治疗方法
WO2018228538A1 (zh) 重组单纯疱疹病毒及其制备方法和应用
JP2011520434A5 (enExample)
Denburg et al. Bone marrow progenitors in inflammation and repair: new vistas in respiratory biology and pathophysiology
JP2013519363A5 (enExample)
Swedin et al. Patient stratification and the unmet need in asthma
Tzouvelekis et al. Stem cell therapy in chronic obstructive pulmonary disease. Seeking the Prometheus effect
Halder et al. Glycyrrhizin loaded hyaluronic acid nanofiber-based artificial saliva for the management of oral mucositis: Preparation, optimization and in-vitro evaluation
JP2016502980A5 (enExample)
JP2017509633A5 (enExample)
Ringdén et al. Successful reversal of acute lung injury using placenta-derived decidual stromal cells
Portacci et al. Dupilumab and Blood Eosinophilia: A Disease‐Specific Phenomenon?
JP2008512491A5 (enExample)
JP2014521675A5 (enExample)